The Enterprise Value as of December 2024 (TTM) for NeuroSense Therapeutics Ltd. (NRSN) is 29.28M

According to NeuroSense Therapeutics Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 29.28M. This represents a change of 50.25% compared to the average of 19.49M of the last 4 quarters.

NeuroSense Therapeutics Ltd. (NRSN) Historical Enterprise Value (quarterly & annually)

How has NRSN Enterprise Value performed in the past?

The mean historical Enterprise Value of NeuroSense Therapeutics Ltd. over the last ten years is 5.71M. The current 29.28M Enterprise Value has changed 51.19% with respect to the historical average. Over the past ten years (40 quarters), NRSN's Enterprise Value was at its highest in in the March 2021 quarter at 44.91M. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.

NeuroSense Therapeutics Ltd. (NRSN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of NeuroSense Therapeutics Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NeuroSense Therapeutics Ltd. (NRSN) Average Enterprise Value

How has NRSN Enterprise Value performed in the past?

The current Enterprise Value of NeuroSense Therapeutics Ltd. (NRSN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

NeuroSense Therapeutics Ltd. (NRSN) Enterprise Value vs. Peers

How is NRSN’s Enterprise Value compared to its peers?

NeuroSense Therapeutics Ltd.’s Enterprise Value is greater than Quoin Pharmaceuticals, Ltd. (-667131.00), greater than Revelation Biosciences, Inc. (-4029924.00), greater than Hillstream BioPharma, Inc. (1.48M), greater than NeuroBo Pharmaceuticals, Inc. (-1181216.00), greater than Virax Biolabs Group Limited (4.10M), less than Nutriband Inc. (37.65M), greater than Longeveron Inc. (4.93M), greater than RenovoRx, Inc. (21.40M), greater than Blue Water Vaccines, Inc. (12.48M), greater than Kiora Pharmaceuticals, Inc. (4.31M), greater than PaxMedica, Inc. Common Stock (371.78K), greater than Allarity Therapeutics, Inc. (-12625909.00), greater than Kiromic BioPharma, Inc. (13.26M), less than Biodexa Pharmaceuticals Plc (790.06M),

Build a custom stock screener for NeuroSense Therapeutics Ltd. (NRSN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeuroSense Therapeutics Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NeuroSense Therapeutics Ltd. (NRSN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NeuroSense Therapeutics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.